PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
TA

Timothy A. Chan

Cancer Immunotherapy and Biomarkers
Seattle Children's Hospital

About

Research focus

Cancer Immunotherapy and Biomarkers

Impact

1,023 pubs · 110,205 cites · h-index 131

Affiliations

Publications

Recent publications by Timothy A. Chan

  1. Quantum convolutional HLA immunogenic peptide prediction (Q-CHIPP): Next-generation neoantigen prediction with quantum neural networkScience Advances · Fri,
  2. Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGClinical Cancer Research · Tue,
  3. Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinomaCancer Cell · Mon,
  4. Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)Cancer Research Communications · Fri,
  5. Neural cell state modulation by PARK2 and dopaminergic neuroprotection by small molecule Parkin agonismSat,
  6. The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programsNature Communications · Fri,
  7. 34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinomaThe Oncologist · Wed,
  8. 62The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programsThe Oncologist · Wed,
  9. MCL1 may not mediate chemoresistanceWed,
  10. Inhibition of KDEL receptors remodels the tumor microenvironment for robust T cell independent tumor regressionMon,